東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Polymyalgia rheumatica and giant cel...

Rovensky, Jozef.

FindBook

Google Book

Amazon

博客來

Polymyalgia rheumatica and giant cell arteritis

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Polymyalgia rheumatica and giant cell arteritis/ edited by Jozef Rovensky ... [et al.].
其他作者:	Rovensky, Jozef.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	viii, 222 p. :ill., digital ;24 cm.
內容註:	Polymyalgia Rheumatica and Giant Cell Arteritis -- an overview with a focus on important factors contributing to the severity of the disease -- Diagnostic criteria for PMR and GCA -- Polymyalgia Rheumatica, Temporal Arteritis and Occurrence of Malignant Tumors - sine syndromes in PMR and GCA -- GCA and Takayasu's disease -- Vascular complications of PMR and GCA -- Coronary involvement and atherosclerosis in Giant Cell Arteritis -- T cells and their role in Polymyalgia Rheumatica -- Cytokines in Polymyalgia Rheumatica and Giant Cell Arteritis -- Genetic factors in Giant Cell Arteritis and Polymyalgia Rheumatica -- Chronobiology of Polymyalgia Rheumatica and Giant Cell Arteritis -- Endocrinologic changes in PMR and GCA -- Imaging techniques, e.g. Ultrasonography, PET/18FDG in PMR and GCA -- Histopathology of Giant Cell (temporal) Arteritis -- changes in aorta -- Management of PMR and GCA -- Biologicals in the treatment of Polymyalgia Rheumatica and Giant Cell Arteritis -- Therapy of resistant forms of PMR and GCA -- Monitoring tools for PMR and GCA.
Contained By:	Springer eBooks
標題:	Polymyalgia rheumatica. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-52222-7
ISBN:	9783319522227

Polymyalgia rheumatica and giant cell arteritis
Polymyalgia rheumatica and giant cell arteritis[electronic resource] /edited by Jozef Rovensky ... [et al.]. - 3rd ed. - Cham :Springer International Publishing :2017. - viii, 222 p. :ill., digital ;24 cm.

Polymyalgia Rheumatica and Giant Cell Arteritis -- an overview with a focus on important factors contributing to the severity of the disease -- Diagnostic criteria for PMR and GCA -- Polymyalgia Rheumatica, Temporal Arteritis and Occurrence of Malignant Tumors - sine syndromes in PMR and GCA -- GCA and Takayasu's disease -- Vascular complications of PMR and GCA -- Coronary involvement and atherosclerosis in Giant Cell Arteritis -- T cells and their role in Polymyalgia Rheumatica -- Cytokines in Polymyalgia Rheumatica and Giant Cell Arteritis -- Genetic factors in Giant Cell Arteritis and Polymyalgia Rheumatica -- Chronobiology of Polymyalgia Rheumatica and Giant Cell Arteritis -- Endocrinologic changes in PMR and GCA -- Imaging techniques, e.g. Ultrasonography, PET/18FDG in PMR and GCA -- Histopathology of Giant Cell (temporal) Arteritis -- changes in aorta -- Management of PMR and GCA -- Biologicals in the treatment of Polymyalgia Rheumatica and Giant Cell Arteritis -- Therapy of resistant forms of PMR and GCA -- Monitoring tools for PMR and GCA.

This book, now in an extensively updated and expanded third edition, offers important insights into polymyalgia rheumatica (PMR) and giant cell arteritis (GCA), providing an overview of their pathophysiology, genetics, immunology, and endocrinological mechanisms but above all presenting the state of the art in diagnosis and treatment. Both PMR and GCA are diseases of advanced age. Early diagnosis and treatment can save one of the most precious senses - vision. In this book, the role of imaging techniques is thoroughly examined, with particular attention to ultrasonography and FDG PET. All aspects of management of both diseases are discussed, including the current use of glucocorticoids, the efficacy of modern biological treatment, such as infliximab, tocilizumab, and rituximab, and the available monitoring tools. Diagnostic criteria for PMR and GCA are outlined, with discussion of differential diagnosis. Among the other topics addressed are disease classification, the histopathology of GCA, the ACR criteria for temporal arteritis, the value of temporal artery biopsy in GCA, serum cytokine profiles, chronobiology, and sine syndromes. The reader will find that the book aids in achieving early diagnosis and providing faster and more effective disease management. General readers with an interest in rheumatology, internal medicine, oftalmology and gerontology will find this book particularly valuable.

ISBN: 9783319522227

Standard No.: 10.1007/978-3-319-52222-7doiSubjects--Topical Terms:

1086681
Polymyalgia rheumatica.

LC Class. No.: RC927.5.P6

Dewey Class. No.: 616.723

Polymyalgia rheumatica and giant cell arteritis
LDR:03443nmm a2200325 a 4500 001 2105763
003 DE-He213
005 20180206110157.0
006 m d
007 cr nn 008maaau
008 180417s2017 gw s 0 eng d
020 $a 9783319522227 $q (electronic bk.)
020 $a 9783319522210 $q (paper)
024 7 $a 10.1007/978-3-319-52222-7 $2 doi
035 $a 978-3-319-52222-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC927.5.P6
072 7 $a MJM $2 bicssc
072 7 $a MED083000 $2 bisacsh
082 0 4 $a 616.723 $2 23
090 $a RC927.5.P6 $b P783 2017
245 0 0 $a Polymyalgia rheumatica and giant cell arteritis $h [electronic resource] / $c edited by Jozef Rovensky ... [et al.].
250 $a 3rd ed.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a viii, 222 p. : $b ill., digital ; $c 24 cm.
505 0 $a Polymyalgia Rheumatica and Giant Cell Arteritis -- an overview with a focus on important factors contributing to the severity of the disease -- Diagnostic criteria for PMR and GCA -- Polymyalgia Rheumatica, Temporal Arteritis and Occurrence of Malignant Tumors - sine syndromes in PMR and GCA -- GCA and Takayasu's disease -- Vascular complications of PMR and GCA -- Coronary involvement and atherosclerosis in Giant Cell Arteritis -- T cells and their role in Polymyalgia Rheumatica -- Cytokines in Polymyalgia Rheumatica and Giant Cell Arteritis -- Genetic factors in Giant Cell Arteritis and Polymyalgia Rheumatica -- Chronobiology of Polymyalgia Rheumatica and Giant Cell Arteritis -- Endocrinologic changes in PMR and GCA -- Imaging techniques, e.g. Ultrasonography, PET/18FDG in PMR and GCA -- Histopathology of Giant Cell (temporal) Arteritis -- changes in aorta -- Management of PMR and GCA -- Biologicals in the treatment of Polymyalgia Rheumatica and Giant Cell Arteritis -- Therapy of resistant forms of PMR and GCA -- Monitoring tools for PMR and GCA.
520 $a This book, now in an extensively updated and expanded third edition, offers important insights into polymyalgia rheumatica (PMR) and giant cell arteritis (GCA), providing an overview of their pathophysiology, genetics, immunology, and endocrinological mechanisms but above all presenting the state of the art in diagnosis and treatment. Both PMR and GCA are diseases of advanced age. Early diagnosis and treatment can save one of the most precious senses - vision. In this book, the role of imaging techniques is thoroughly examined, with particular attention to ultrasonography and FDG PET. All aspects of management of both diseases are discussed, including the current use of glucocorticoids, the efficacy of modern biological treatment, such as infliximab, tocilizumab, and rituximab, and the available monitoring tools. Diagnostic criteria for PMR and GCA are outlined, with discussion of differential diagnosis. Among the other topics addressed are disease classification, the histopathology of GCA, the ACR criteria for temporal arteritis, the value of temporal artery biopsy in GCA, serum cytokine profiles, chronobiology, and sine syndromes. The reader will find that the book aids in achieving early diagnosis and providing faster and more effective disease management. General readers with an interest in rheumatology, internal medicine, oftalmology and gerontology will find this book particularly valuable.
650 0 $a Polymyalgia rheumatica. $3 1086681
650 0 $a Giant cell arteritis. $3 1086680
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Rheumatology. $3 894494
650 2 4 $a Geriatrics/Gerontology. $3 894395
700 1 $a Rovensky, Jozef. $3 1086679
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-52222-7
950 $a Medicine (Springer-11650)